PAPI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 35.512
AS - Asia 17.776
EU - Europa 10.345
SA - Sud America 3.451
AF - Africa 333
OC - Oceania 153
Continente sconosciuto - Info sul continente non disponibili 24
Totale 67.594
Nazione #
US - Stati Uniti d'America 34.865
SG - Singapore 7.466
CN - Cina 4.330
BR - Brasile 2.840
HK - Hong Kong 2.137
IT - Italia 2.049
UA - Ucraina 1.855
DE - Germania 1.778
VN - Vietnam 1.201
TR - Turchia 1.093
GB - Regno Unito 1.071
FI - Finlandia 732
NL - Olanda 666
RU - Federazione Russa 611
SE - Svezia 529
ID - Indonesia 456
MX - Messico 333
PL - Polonia 260
IN - India 258
AR - Argentina 245
CA - Canada 243
FR - Francia 201
AU - Australia 135
BD - Bangladesh 125
JP - Giappone 123
ZA - Sudafrica 123
AT - Austria 115
EC - Ecuador 102
ES - Italia 98
IQ - Iraq 87
BE - Belgio 69
CO - Colombia 62
LT - Lituania 62
KR - Corea 61
PK - Pakistan 61
PY - Paraguay 60
TW - Taiwan 55
CZ - Repubblica Ceca 47
VE - Venezuela 43
MA - Marocco 42
EG - Egitto 39
KE - Kenya 36
AE - Emirati Arabi Uniti 34
PE - Perù 34
UZ - Uzbekistan 33
CL - Cile 28
IE - Irlanda 27
MY - Malesia 27
CH - Svizzera 26
UY - Uruguay 25
SA - Arabia Saudita 22
DZ - Algeria 21
TH - Thailandia 21
TN - Tunisia 21
IR - Iran 20
PH - Filippine 19
KZ - Kazakistan 18
PT - Portogallo 18
AL - Albania 17
NZ - Nuova Zelanda 17
JO - Giordania 16
IL - Israele 15
NP - Nepal 15
GR - Grecia 14
EU - Europa 13
DO - Repubblica Dominicana 12
HR - Croazia 12
LB - Libano 12
RO - Romania 12
RS - Serbia 10
BG - Bulgaria 9
BO - Bolivia 9
HU - Ungheria 9
NG - Nigeria 9
XK - ???statistics.table.value.countryCode.XK??? 9
AZ - Azerbaigian 8
HN - Honduras 8
JM - Giamaica 8
MK - Macedonia 8
VI - Stati Uniti Isole Vergini 8
CR - Costa Rica 7
GE - Georgia 7
AO - Angola 6
DK - Danimarca 6
ET - Etiopia 6
GT - Guatemala 6
MN - Mongolia 6
PA - Panama 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
BN - Brunei Darussalam 5
MD - Moldavia 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
BY - Bielorussia 4
CG - Congo 4
CI - Costa d'Avorio 4
KH - Cambogia 4
LK - Sri Lanka 4
Totale 67.514
Città #
Singapore 4.178
Fairfield 4.047
Woodbridge 3.629
Ashburn 3.319
Houston 2.638
Hong Kong 2.117
Jacksonville 2.039
Chandler 1.631
Santa Clara 1.559
Seattle 1.514
Wilmington 1.435
Ann Arbor 1.327
Cambridge 1.319
Dallas 1.247
Beijing 1.189
Izmir 700
Nanjing 636
Princeton 564
Los Angeles 538
Munich 519
Ho Chi Minh City 399
San Diego 370
Jakarta 357
Ferrara 345
New York 331
Boardman 308
Milan 282
Hanoi 240
Washington 237
São Paulo 236
Warsaw 235
Mexico City 229
Chicago 217
Nanchang 194
Shanghai 193
Shenyang 171
Tianjin 170
Helsinki 160
Hefei 154
Moscow 141
London 138
Addison 131
Buffalo 127
Hebei 124
Changsha 111
Dearborn 108
Nuremberg 102
Jiaxing 100
Rome 100
Lappeenranta 99
Tokyo 94
Turku 93
Dong Ket 90
Rio de Janeiro 90
Mountain View 86
Council Bluffs 84
Falls Church 79
Denver 77
Redwood City 74
Brooklyn 73
Falkenstein 72
Toronto 70
Zhengzhou 70
Frankfurt am Main 68
Norwalk 66
Boston 65
The Dalles 64
Bologna 63
Montreal 63
Orem 61
Guangzhou 59
Vienna 59
Belo Horizonte 58
Chennai 56
Stockholm 55
Atlanta 53
Da Nang 52
Jinan 52
Curitiba 50
Haiphong 50
Kunming 50
Bremen 49
Johannesburg 48
Ningbo 48
San Francisco 47
Brussels 46
Orange 46
Phoenix 45
Verona 45
Campinas 40
Manchester 40
Poplar 39
Amsterdam 38
Brasília 38
Columbus 36
San Mateo 36
Americana 35
Ankara 35
Baghdad 34
Guayaquil 34
Totale 45.129
Nome #
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 638
Asthma 452
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 385
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 323
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 317
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 312
Targeting Th2 cells in asthmatic airways 277
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 267
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 263
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial 258
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 240
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 223
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 219
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 216
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 213
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 211
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 209
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 207
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 206
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 205
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 203
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 201
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 199
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 198
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 195
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 191
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 191
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 191
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 191
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 190
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 186
Malattie polmonari primitive da cause dismetaboliche. 184
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 182
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion 181
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 181
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS) 180
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 178
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 176
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial 176
Activation of NF-kappaB transcription factor in asthma death 175
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 175
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 174
COPD: early diagnosis and treatment to slow disease progression 174
A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice? 174
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma 174
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 174
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 173
Models of infection and exacerbations in COPD. 172
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 172
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 172
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 172
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 171
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 171
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 169
A serum proteome signature to predict mortality in severe COVID-19 patients 168
Management of bronchial asthma 167
A defective type 1 response to rhinovirus in atopic asthma 167
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 167
Rhinovirus vaccination: the case against 166
Asthma management 165
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 165
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 164
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 163
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 163
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 163
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 163
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 163
Enfisema polmonare: prospettive di terapia 162
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis 162
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 162
INSTEAD: A randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD 160
Apporto esogeno di riducenti e attività del rinovirus HRV16 160
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 159
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 159
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma 159
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 159
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 159
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 158
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 157
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease 157
Extrafine beclometasone diproprionate/formoterol fumarate: A review of its effects in chronic obstructive pulmonary disease 157
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 157
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 157
Mechanisms of rhinovirus-induced asthma 157
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 156
Association between markers of emphysema and more severe chronic obstructive pulmonary disease 156
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 156
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 156
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare. 155
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 155
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 154
True tracheal bronchus 154
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 154
Cellule staminali e patologia polmonare dell’adulto 153
COPD exacerbations: definitions and classifications 153
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma. 153
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 153
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. 152
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies 152
Totale 19.150
Categoria #
all - tutte 349.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 16.061
Totale 365.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.205 0 0 0 0 0 681 279 751 170 784 881 659
2021/20225.146 219 452 320 258 197 236 283 293 204 380 461 1.843
2022/20234.213 575 103 145 491 619 645 179 385 531 65 314 161
2023/20242.742 248 267 113 83 137 279 78 136 88 259 348 706
2024/202511.287 303 293 998 331 1.307 813 351 716 1.934 1.653 1.447 1.141
2025/202618.781 2.708 1.677 3.921 4.389 4.661 1.425 0 0 0 0 0 0
Totale 68.859